Improvement of Glycaemia and Endothelial Function by a New Low-Dose Curcuminoid in an Animal Model of Type 2 Diabetes

Curcumin has been suggested as a promising treatment for metabolic diseases, but the high doses required limit its therapeutic use. In this study, a new curcuminoid is synthesised to increase curcumin anti-inflammatory and antioxidant potential and to achieve hypoglycaemic and protective vascular ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliveira, Sara, Monteiro-Alfredo, Tamaeh, Henriques, Rita, Ribeiro, Carlos Fontes, Seiça, Raquel, Cruz, Teresa, Cabral, Célia, Fernandes, Rosa, Piedade, Fátima, Robalo, Maria Paula, Matafome, Paulo, Silva, Sónia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144453/
https://www.ncbi.nlm.nih.gov/pubmed/35628465
http://dx.doi.org/10.3390/ijms23105652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144453/
https://www.ncbi.nlm.nih.gov/pubmed/35628465
http://dx.doi.org/10.3390/ijms23105652

Ejemplares similares